Explore the latest in rhythm disorders, including advances in treatment and recent guidelines for atrial fibrillation, SVT, VT/VF, and more.
This clinical trial evaluates whether linear ablation combined with ethanol infusion of the vein of Marshall and pulmonary vein isolation (PVI) is more effective than PVI alone in patients with persistent atrial fibrillation.
This randomized clinical trial examines whether a partial cardiac denervation procedure reduces the incidence of postoperative atrial fibrillation among patients undergoing isolated coronary artery bypass grafting (CABG) in China.
This randomized clinical trial compares ablation-first vs occlusion-first strategies for patients with atrial fibrillation undergoing combined left atrial appendage occlusion and catheter ablation.
This JAMA Clinical Guidelines Synopsis summarizes the 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation.
This Viewpoint describes the diffusion of direct-to-consumer wearable devices capable of early atrial fibrillation detection and the unclear implications for initiation of anticoagulation therapy based on such findings.
This stepped-wedge cluster randomized clinical trial evaluates a multipronged physician-directed intervention with clinical decision support of anticoagulation initiation for eligible adult emergency department patients.
This cohort study examines the association between resting heart rate and new-onset atrial fibrillation in a large community-based sample of Black adults in Jackson, Mississippi.
This cross-sectional study examines survey data from a 4-day nationwide telephone survey in Taiwan about awareness of and willingness to use automated external defibrillators.
This meta-analysis assesses the prevalence of ventricular and supraventricular arrhythmias, left ventricular dysfunction, heart failure, myocardial infarction, and death among patients who were treated with chimeric antigen receptor (CAR) T-cell products.
This randomized clinical trial assesses the role of antitachycardia pacing in terminating fast ventricular tachycardia in primary prevention patients with implantable cardioverter-defibrillators with contemporary programming.
This randomized clinical trial assesses whether cardioverter-defibrillator implantation is more effective than amiodarone therapy for the primary prevention of all-cause mortality and secondary prevention of sudden cardiac death, hospitalization for heart failure, and use of a pacemaker among patients with chronic Chagas cardiomyopathy.
This randomized clinical trial investigates if adding additional lesions next to the index effective ablation site will improve the ablation outcomes of outflow tract premature ventricular contractions (PVCs).
This case series study examines the clinical and histopathologic spectrum of cutaneous findings in patients with germline SUFU pathogenic variants.
This cohort study assesses the association between initial defibrillator pad placement position and out-of-hospital cardiac arrest among patients treated by emergency medical services in the United States.
Customize your ÌÇÐÄvlog experience by selecting one or more topics from the list below.